Thomas Erker

Drug trapping in hERG K+ channels: (not) a matter of drug size?† †The authors declare no competing interests.

Steffen Hering, Tobias Linder, Priyanka Saxena, 2015, MedChemComm.

Using structural and mechanistic information to design novel inhibitors/substrates of P-glycoprotein.

Markus Müller, Peter Chiba, Thomas Stockner, 2010, Current topics in medicinal chemistry.

'Bridged' stilbene derivatives as selective cyclooxygenase-1 inhibitors.

Walter Jaeger, Norbert Handler, W. Jaeger, 2007, Bioorganic & medicinal chemistry.

Studies on the chemistry of O,N- and S,N-containing heterocycles. 12 [1]. Investigations on the synthesis of tricyclic 1,5-benzoxazepines

T. Erker, Thomas Erker, Herbert Bartsch, 1990 .

Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.

Walter Jaeger, T. Szekeres, W. Jaeger, 2005, Experimental hematology.

Tariquidar and Elacridar Are Dose-Dependently Transported by P-Glycoprotein and Bcrp at the Blood-Brain Barrier: A Small-Animal Positron Emission Tomography and In Vitro Study

Claudia Kuntner, Albert D. Windhorst, Wolfgang Löscher, 2013, Drug Metabolism and Disposition.

The way-below relation of function spaces over semantic domains

Klaus Keimel, Martín Hötzel Escardó, Thomas Erker, 1998 .